|
Match
|
Document |
Document Title |
|
|
6277396 |
Dietary supplement containing a thermogenic substance and an adrenal support substance
A dietary supplement system having a daytime component and a nighttime component is provided, wherein the daytime component comprises at least one thermogenic substance and the nighttime component...
|
|
|
6277827 |
Single morphic forms of metalloproteinase inhibitors
A single morphic form of a compound selected from 2S-[4-(2,5-dioxopyrrolidin-1-yl)-2S-mercaptobutyrylamino]-4-
methylpentanoi c acid (2,2-dimethyl-1S-methylcarbamoylpropyl)amide and...
|
|
|
6274169 |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
The invention relates to stable compositions comprising 1α, 25-dihydroxycholecalciferol, a unit dose system comprising the same in a sealed vessel, and a process for preparing them.
|
|
|
6274175 |
Prolonged release of GM-CSF
Formulations for controlled, prolonged release of GM-CSF have been developed. These are based on solid microparticles formed of the combination of biodegradable, synthetic polymers such as...
|
|
|
6271258 |
Process for the preparation of stable, non-hygroscopic salts of L(-)carnitine
An improved process for producing stable, non-hygroscopic salts of l(-)carnitine is disclosed, which comprises preparing at room temperature a pasty/semiliquid slurry of L(-)carnitine inner salt...
|
|
|
6270797 |
Sustained release pharmaceutical composition containing glipizide and method for producing same
One aspect of the invention resides in a monolithic sustained release composition of glipizide for patients with non-insulin dependent diabetes mellitus that exhibits a breakdown after ingestion by...
|
|
|
6267985 |
Clear oil-containing pharmaceutical compositions
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6267972 |
Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists
Cosmetic/pharmaceutical compositions, well suited for the treatment of a variety of mammalian disorders of, for example, the skin, hair and/or mucous membranes, a manifestation of which is an...
|
|
|
6267969 |
Unit-of-use reagent composition for specific binding assays
Unit-of-use reagent compositions and methods for preparing such reagent compositions are disclosed. The reagent composition comprises one or more reagents which are necessary for a specific binding...
|
|
|
6267980 |
Dosage forms and uses
A pharmaceutical dosage form comprises, in a portion thereof, substantially single enantiomer (R)-verapamil and, in another, separate, portion thereof, substantially single enantiomer...
|
|
|
6264989 |
Spherical single-substance particles, medicines and foodstuffs containing the particles, and method of production thereof
The present invention relates to a process for producing a spherical particle comprising an aggregate of particles containing at least 95% of a water-soluble single substance having a viscosity of...
|
|
|
6264941 |
Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
This invention provides improved devices and methods for long-term, stable expression of a biologically active molecule using a biocompatible capsule containing genetically engineered cells for the...
|
|
|
6264981 |
Oral transmucosal drug dosage using solid solution
The present invention is directed toward formulation and method for oral transmucosal delivery of a pharmaceutical. The invention provides a drug formulation comprising a solid pharmaceutical agent...
|
|
|
6261598 |
Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein
Carotenoid formulations comprising a mixture of β-carotene, lycopene and lutein, and the use thereof in human and animal foods, cosmetics and pharmaceuticals.
|
|
|
6258380 |
Chewable soft capsule
The present invention comprises chewable, soft gelatin capsules having a sheath formed of a mixture of a low bloom and a medium bloom gelatins, a plasticizer, water, and preferably a moisture...
|
|
|
6258379 |
Analgesic dosage units for coordinated administration
A pharmaceutical dispensing kit that includes at least two different analgesic dosage units that have been formulated for use with each other, each of the analgesics being formulated for...
|
|
|
6254882 |
Methods and compositions for treating pulmonary disorders using optically pure (S)--salmeterol
A method and composition are disclosed utilizing the pure (S) isomer of salmeterol which is a potent bronchodilator with reduced adverse effects, having a better selectivity for β 2 receptors...
|
|
|
6255280 |
Protection against traumatic brain injury
The present invention relates to therapeutic uses of cyclosporin A to reduce adverse effects of neural injury.
|
|
|
6251421 |
Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
The present invention provides orally administrable pharmaceutical compositions containing an inhibitor of gastrointestinal lipase, and at least one compound selected from the group consisting of...
|
|
|
6251427 |
Pharmaceutical capsule compositions containing loratadine and psuedoephedrine
A pharmaceutical capsule composition for oral administration exhibiting controllable, satisfactory release profiles of both loratadine and pseudoephedrine or its salts, which comprises: (a) a...
|
|
|
6251426 |
Ibuprofen-containing softgels
Liquid softgel fill formulations containing ibuprofen in free acid form, and softgel capsules comprised of a gelatin sheath enclosing such fill formulations, are prepared by dissolving more than...
|
|
|
6248355 |
Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
A composition, particularly adapted for oral administration, containing omeprazole, and a method for preparing the composition, are disclosed. The composition, being exempt of alkaline-reacting...
|
|
|
6248308 |
Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
Methods and pharmaceutical compositions employing norastemizole and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma or the symptoms...
|
|
|
6248307 |
Compositions and treatment for alleviation of symptoms associated with menopause
A composition having at least one herbal compound and at least one homeopathic drug is useful for treating symptoms associated with menopause. Methods of preparing the composition and methods of...
|
|
|
6242012 |
Herbal composition for promoting hormonal balance in women and methods of using same
An herbal composition which can be used to alleviate the symptoms associated with hormonal imbalance in women contains supercritical extracts of ginger, rosemary and evening primrose oil, and...
|
|
|
6242000 |
Composition of S-sodium ibuprofen
The use of S(-)sodium 2-(4-isobutylphenyl)propionate (the sodium salt of S(+)-ibuprofen) in pharmaceutical compositions for the treatment of inflammation, pain and pyrexia is described. Preferred...
|
|
|
6241987 |
Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
A dietary supplement and method for supporting and maintaining normal prostrate gland function is described. The dietary supplement of the present invention provides a unique combination of herbal...
|
|
|
6242006 |
β-lactam granules free of organic solvents
β-Lactam granules free of organic solvents have been provided for. Also a process to prepare the same by applying during the granulation only water as binding solvent has been disclosed.
|
|
|
6235304 |
Method of inhibition of HIV replication by leukemia inhibitory factor
The present invention concerns a method for inhibiting HIV replication in a cell by binding Leukemia Inhibitory Factors ("LIF") LIF to its receptor in a cell to inhibit HIV replication within the...
|
|
|
6231887 |
Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
The present invention provides a novel pharmaceutical composition based on the use of a particular amount of basic amine which comprises a pyranone compound as a pharmaceutically active agent, a...
|
|
|
6228394 |
Supercritical fluid extraction of mould lubricant from hard shell capsules
Hard shelled capsules and dry, powdered pharmaceutical formulations are treated with supercritical fluids to remove impurities such as mold lubricants and moisture.
|
|
|
6228894 |
Softgel-compatible composition containing retinol
A softgel-compatible composition containing retinol comprises retinol-impregnated microparticles. The composition may include an optionally thickened silicone oil, or may include an emulsion...
|
|
|
6228387 |
Integrated comprehensive hemorrhoid treatment compositions and regimen
A first composition for topical application and a second for oral administration, make up a comprehensive program for the treatment and relief of hemorrhoids. The topical application composition...
|
|
|
6228400 |
Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
The present invention provides pharmaceutical formulations which contain (a) an inert core of sugar, sugar and starch, or microcrystalline cellulose, (b) a drug emulsion layer which is made from...
|
|
|
6224910 |
Method for the preparation of an enteric coated high drug load pharmaceutical composition
A high drug load enteric coated pharmaceutical composition is provided which includes a core comprised of a medicament which is sensitive to a low pH environment of less than 3, such as ddl, which...
|
|
|
6224908 |
Flow controller configurations for an active agent delivery device
Oral active agent delivery system having improved flow controllers. A hollow tubular member containing the active agent formulation and having a fluid passing controller is placed at one end into a...
|
|
|
6224906 |
St. John's wort composition
A composition of St. John's Wort, in the form of a stable, free-flowing, powder, having effective antidepressant properties, characterized by having essentially no hypericin therein.
|
|
|
6217603 |
Methods of applying monomeric compositions effective as wound closure devices
A method of joining together in vivo living tissue surfaces includes (a) holding together at least two tissue surfaces to form abutted tissue surfaces, (b) applying across the abutted tissue...
|
|
|
6217906 |
Self adjustable exit port
A delivery device having a first chamber containing an osmotic agent, a membrane forming a wall of the first chamber through which fluid is imbibed by osmosis, a second chamber containing a...
|
|
|
6217898 |
Pharmaceutical composition comprising carnitine or alkanoyl L-carnitine, for the prevention and treatment of diseases brought about by lipid metabolism disorders
A pharmaceutical compositions comprising L-carnitine or alkanoyl L-carnitine and hydroxycitric or pantothenic acid or derivatives thereof for the prevention and treatment of diseases brought about...
|
|
|
6214376 |
Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
Gelatin-free capsule for use in oral administration of medicines, cosmetic or bath applications, or dietary supplements can be prepared from compositions comprising a) 8-50% by weight of...
|
|
|
6214373 |
Nutritional composition for treating inflammatory bowel diseases
A nutritional composition and method useful for treatment of inflammatory bowel diseases is disclosed, the composition comprising selected vitamins and mineral salts for oral administration to a...
|
|
|
6214378 |
Capsules for oral preparations and capsule preparations for oral administration
This invention offers capsules for oral preparation which is useful for colon diseases such as colon cancer, ulcerative colitis, constipation and diarrhea and for systemic diseases such as...
|
|
|
6214379 |
Maximizing effectiveness of substances used to improve health and well being
The present disclosure relates to novel dosage forms, drug delivery regimens, methods and pharmaceutical compositions which optimize the therapeutic effects of active therapeutic substances through...
|
|
|
6214349 |
Composition for limiting the assimilation of dietary fat and methods of making and using same
The present invention is an dietary supplement which inhibits the assimilation of dietary fat during digestion, and method of making and using the same. The composition includes surfactant and...
|
|
|
6210709 |
Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
A flexible capsule formed from a modified starch free of animal based gelatin. The invention provides a novel capsule defining a closed interior chamber, the capsule being formulated from a...
|
|
|
6207188 |
Omeprazole sodium salt
This invention relates to a novel form of the sodium salt of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sul
finyl]-1H-benz imidazole, known under the generic name omeprazole sodium...
|
|
|
6207189 |
Procedure for the production of capsules and tablets of natural substances of vegetable origin
A procedure for the production of tablets and capsules of natural substances of vegetable origin, in which dry extracts and micronized powders of one or more medicinal herbs are mixed in...
|
|
|
6207198 |
Composition containing an acid-labile omeprazole and process for its preparation
|
|
|
6200600 |
Controlled delay release device
Novel devices for the controlled release of active materials especially pharmaceuticals comprise a capsule formed from two separable pieces at least part of the capsule walls is water permeable....
|